Microbiology

The researchers also attempted to map the genome of a woman

Over past years, we have seen an increase in the number of cases in countries where monkeypox is endemic and also exists in wildlife

Ljubljana – Only a day after confirming its first case of monkeypox, Slovenia reported a second case of infection with the virus on Wednesday. Like the first case, the infected person had travelled to Spain, the National Institute of Public Health (NIJZ) has announced on its website.

As stated, this strain is likely to spread around the world, and a larger increase in the number of infected could have severe consequences in some areas.
Although it is not yet known to what extent omicron is contagious for those who have been vaccinated and recovered from COVID-19, the WHO recommends accelerated vaccination of risk groups.

As of today, governments across Europe are rushing to step up their defenses against a possible new coronavirus outbreak after South Africa announced the discovery of a new strain of Covid-19 that scientists fear could thwart the pandemic effort.

The number of deaths from complications after coronavirus infection in the past 24 hours in Ukraine is 734, which is the highest figure for the entire pandemic. This was announced on Tuesday by the Ministry of Health of the country, quoted by TASS.

If we continue to have low immunization coverage, I would not be surprised if a variant of Bulgarian origin appears. Upon entering a host, the virus seems to borrow life and begin to dictate conditions. The more passages pass from person to person, the more we allow the virus to improve. That's why these variants appeared.

The documents contradict Fauci’sclaim that no gain of function research was funded by the US at the Lab in Wuhan

In a week or two we will have over 1,000 coronavirus cases a day and we will enter the orange zone, Prof. Iva Hristova, director of the National Center for Infectious and Parasitic Diseases, has told the Bulgarian National Radio.

Ljubljana – A group of Slovenian researchers has created software that helps scientists analyse the content of microbiomes, the communities of microorganisms living in the human gut, in order to detect specific pathways that may indicate the presence of a disease. The discovery creates opportunities for the development of new personalised-medicine therapies.